Disulfiram/Copper Induces Antitumor Activity against Both Nasopharyngeal Cancer Cells and Cancer-Associated Fibroblasts through ROS/MAPK and Ferroptosis Pathways
Disulfiram/copper (DSF/Cu) is a promising antitumor reagent for clinical application due to its excellent anticancer activity and safety. However, the anticancer mechanism of DSF/Cu has not been fully elucidated. Our study showed that DSF/Cu strongly induced cytotoxic effects on both nasopharyngeal...
Main Authors: | Yiqiu Li, Fangfang Chen, Jun Chen, Siocheong Chan, Yi He, Wanli Liu, Ge Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/1/138 |
Similar Items
-
Drug Repurposing as an Antitumor Agent: Disulfiram-Mediated Carbonic Anhydrase 12 and Anion Exchanger 2 Modulation to Inhibit Cancer Cell Migration
by: Soyoung Hwang, et al.
Published: (2019-09-01) -
Disulfiram, a Ferroptosis Inducer, Triggers Lysosomal Membrane Permeabilization by Up-Regulating ROS in Glioblastoma
by: Qiu C, et al.
Published: (2020-10-01) -
Overcoming the compensatory elevation of NRF2 renders hepatocellular carcinoma cells more vulnerable to disulfiram/copper-induced ferroptosis
by: Xueying Ren, et al.
Published: (2021-10-01) -
In situ triggering antitumor efficacy of alcohol-abuse drug disulfiram through Cu-based metal-organic framework nanoparticles
by: Lin Hou, et al.
Published: (2021-07-01) -
Overview of Antabuse® (Disulfiram) in Radiation and Cancer Biology
by: Jia Y, et al.
Published: (2021-05-01)